Biosensors market to reach USD 53.59B by 2031

Biosensors market size was valued at around USD 26.76 billion in 2022 and is poised to grow from USD 28.9 billion in 2023 to USD 53.59 billion by 2031, at a CAGR of 8.0% over the forecast period (2024–2031).

The healthcare industry is using biosensors more and more to monitor a range of parameters, including blood glucose levels in diabetic patients. In addition, necessity for biosensors to detect heavy substances in food and water is increasing, and their application in environmental monitoring, medical, and agricultural fields is expanding. These factors are anticipated to fuel the revenue expansion of the biosensors market. To introduce biosensors that are more complex and inventive, companies within the industry are heavily investing in R&D. This approach is anticipated to rise the market’s revenue significantly, as level 4 and 5 electric vehicles (EVs) develop greater autonomy and self-driving capabilities.

Advancing innovation in detection through biosensors
The global biosensors market is rising rapidly due to technical developments and rise in demand for accurate and dependable diagnostic tools across a variety of industries. The industry’s leading companies are well-known, having a large range of products, strong distribution networks, and recognizable trademarks. They are investing a lot of money in R&D to keep their competitive advantage and supply their client with cutting-edge biosensor technology. SkyQuest